Capsida Biotherapeutics Opens New Facility In Thousand Oaks

socalTECH

Thousand Oaks-based biotech company Capsida Biotherapeutics says it has opened up a new, 15,000 square-foot facility in Thousand Oaks for its gene therapy manufacturing efforts. The company is developing targeted adeno-associated virus (AAV) gene therapies for patients with debilitating and life-threatening genetic disorders. The company says that building its own manufacturing facility will help it eliminate dependence on ontract manufacturing.

Uber Used In Drug Deal In Thousand Oaks

socalTECH

The Ventura County Sheriff''s department reported this morning that it arrested two suspects in Thousand Oaks, who were using Uber to help conduct deals. According to the Sheriff''s Department, Cody Jens (24) of Agoura Hills, and Luke Karasiuk (22) of Thousand Oaks were arrested after local police made a vehicle code enforcement stop on an Uber driver on Wednesday morning. uber drug deal thousand oaks ventura county crime criminal mobile

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

Atara Biotherapeutics Leases New Space In Thousand Oaks

socalTECH

Thousand Oaks-based Atara Biotherapeutics , which is developing treatments for patients with cancer, autoimmune and infectious disease, has leased a 90,000 square foot building in the Conejo Spectrum, according to developer SARES-REGIS Group. atara biotherapeutics biopharmaceuticals expansion growth thousand oaks ventura county

Amgen Chops Staff In Thousand Oaks

socalTECH

Thousand Oaks-based Amgen said Wednesday afternoon that it is cutting 380 jobs from the firm, as part of a corporate restructuring. The firm said it is cutting 226 people in its Thousand Oaks headquarters. amgen thousand oaks jobs employment employer layoffThe firm said most of the positions are in its research and development division, and that it is notifying its employees today. READ MORE>>.

HARDATA Sets Up Shop In Thousand Oaks

socalTECH

HARDATA , a developer of workflow management software for the broadcast and entertainment industry, has set up shop in Thousand Oaks, and hired a new President and CEO. The Argentina-based software developer said it has named Philip B. Cox as President and CEO, and opened up its world headquarters in the United States. Cox has previously served at such firms as CalAmp, Signal Technology COrp. M/A/Com, Inc., and 360 Systems.

Report: Oxnard-Thousand Oaks-Ventura Among Top Spots For CEOs

socalTECH

The Oxnard-Thousand Oaks-Ventura metro area has made a list of the top areas where CEOs live , published in this week''s Wall Street Journal. executives ceos jobs employment ventura oxnard oaks thousand The report--ranking the percentage of residents identified as CEOs--said 1.21% of residents in the metro workforce were CEOs.

Thousand Oaks Biopharmaceuticals Gets $45M In Series A For Biotech Manufacturing

socalTECH

Thousand Oaks- and Shanghai-based Thousand Oaks Biopharmaceuticals , a new contract manufacturing organization fort he biotech industry, said it has received $45M in a Series A financing round. The funding came from New Alliance Capital, plus ADDOR Capital, Tenyall & Sumin, Broadhi Capital, QianRong, Ji Lin Ao Dong, and Bluebay Capital.

Amgen Acquires Five Prime Therapeutics For $1.9 Billion

socalTECH

Thousand Oaks-based. amgen five prime therapeutics merger acquisition clinical oncology cancer biotech lifescience

Servoy Releases Update

socalTECH

Thousand Oaks-based Servoy , a developer of software for creating web-based applications, said Friday that the firm has upgraded its products. Tags: servoy thousand oaks software saas The firm said its product allows companies to build software applications that run both through a browser and through native desktop applications. The firm said the latest update, version 4.1, includes over 350 enhancements and fixes.

Amgen Completes $3.7B Chemocentryx Buy

socalTECH

Thousand Oaks-based biotech giant Amgen said today that it has completed its $3.7 billion acquisition of ChemoCentryx, a biopharmaceuticals company which develops orally administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer. Amgen paid $52 per share in cash for Chemocentryx. Chemocentryx's lead product is TAVNEOS, an FDA-approved product which is used to treat severe active ANCA-associated vasculitis.

Amgen To Award Lab Space, Support To Karma Biotechnologies

socalTECH

Thousand Oaks-based Amgen and share lab provider Biolabs LA said Monday that they have awarded Karma Biotechnologies one year of lab space at Biolabs, as well as other facility benefits and connections to Amgen's scientific and business leaders.

Amgen Buys Chemocentryx For $4 Billion In Cash

socalTECH

Thousand Oaks-based biotech giant Amgen says it is acquiring ChemoCentryx, a publicly traded biopharmaceuticals company which is focused on orally administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer. The company said it will pay $52 per share in cash for ChemoCentryx, with an enterprise value of approximately $3.7 billion. Amgen was advised by PJT Partners, with legal advice from Wachtell, Lipton, Rosen & Katz.

Amgen Commits $30M For Virtual Science Education

socalTECH

Thousand Oaks-based The Amgen Foundation, the charitable arm of Amgen, said Monday that it has committed $30M to LabXChange, an online science education platform. According to Amgen, it is the founding and lead sponsor of the effort, which it is a collaboration with Harvard's Vice Provost of Advances in Learning. Amgen had previously donated $13M to the effort.

Amgen Acquires Teneobio For $900M

socalTECH

Thousand Oaks-based Amgen said on Tuesday that it will pay $900M for Teneobio, a biopharmaceuticals company which is developing treatments for patients with cancer. According to Amgen, the all cash $900M deal also includes future contingent milestone payments worth up to an additional $1.6 billion in cash. Teneobio has a variety of early-stage oncology assets, including a Phase I bispecific antibody for patients with advanced prostate cancer, according to Amgen.

Startup Demo Competition

SoCal Tech Calendar

805 Startups is partnering with the City of Thousand Oaks to hold a startup demo competition at their beautiful Thousand Oaks Civic Arts Plaza. Wednesday, July 26, 2017 -- Startup Demo Competition. The selected startups will present in front of an audience of 400 people from across Southern California and to a panel of judges made up of ACTIVE startup investors (angels and VCs). See [link] (more

Amgen Cuts 300 In San Francisco

socalTECH

Thousand Oaks-based biotech Amgen is cutting 300 jobs in San Francisco, as part of a shutdown of the South San Francisco operations of subsidiary Onyx Pharmaceuticals , according to a memo leaked from the company on Tuesday. Amgen plans to transfer workers in San Francisco back to its Thousand Oaks headquarters.

Amgen Completes Five Prime Therapeutics Deal

socalTECH

Thousand Oaks-based Amgen said this morning that it has successfully completed its $1.9 billion acquisition of Five Prime Therapeutics, a clinical-stage biotechnology company focused on developing immuno-oncology and targeted cancer therapies. Amgen paid $38.00 per share in cash for Five Prime Therapeutics. Five Prime's programs include bemarituzumab, a Phase 3 trial-ready, first-in-class program for gastric cancer.

Amgen Acquires Rodeo Therapeutics

socalTECH

Thousand Oaks-based Amgen and Rodeo Therapeutics Corporation announced late Tuesday that Amgen has agreed to acquire Rodeo, a Seattle-based biopharmaceuticals company which is developing small molecule therapies to promote regeneration and repair of multiple tissues.

Amgen To Cut Nearly 3,000

socalTECH

Thousand Oaks-based biotechnology giant Amgen said Tuesday that it plans to cut 2,400 to 2,900 staff, including at its headquarters location, and will also close facilities in both Washington and Colorado. As part of the move, Amgen said it will also consolidate staff into less buildings in the Thousand Oaks area. Amgen did not say how many of its staff in Thousand Oaks would be cut.

Teledyne Clears Two Antitrust Reviews For FLIR Acquisition

socalTECH

Thousand Oaks-based Teledyne Technologies Incorporated says it has cleared antitrust reviews in both Canada and Canada for its ongoing acquisition of FLIR Systems. According to the company, it received a No-Action Letter regarding the proposed acquisition from the Competition Bureau of the Government of Canada on Wednesday, and a similar one from the Federal Cartel Office in Germany.

Teledyne Acquires FLIR For $8.0 Billion

socalTECH

Thousand Oaks-based Teledyne Technologies said today that it has agreed to acquire FLIR Systems, which develops infrared cameras and similar technology, in a deal worth $8.0 billion. According to Teledyne, the cash and stock transaction is split between $28.00 per share in cash and 0.0718 shares of Teledyne common stock for each FLIR share. Both companies develops sensors, cameras, and sensor systems. Teledyne said that it is funding the death through a $4.5

Atara Biotherapeutics CEO Steps Down

socalTECH

Atara Biotherapeutics , the biopharmaceuticals firm which has its manufacturing and research efforts based in Thousand Oaks, said on Thursday that its current President and CEO, Isaac Ciechanover, M.D., The company is based in South San Francisco, but was founded in Thousand Oaks and has a large facility in the city.

California Lutheran University Names Executive- and Entrepreneur-In-Residence

socalTECH

Thousand Oaks-based California Lutheran University and its School of Management said on Monday that it has named both an Executive-In-Residence and Entrepreneur-In-Residence to the school. The school said Primo Custodio, most recently VP for Human Resources at NBC Universal, will become Executive-in-Residence for the business school, and Jim Cathcart, a motivational speaker and author, becomes Entrepreneur-in-Residence.

Teledyne Buys Photon Machines

socalTECH

Thousand Oaks-based Teledyne Technologies said last week that it has acquired Photon Machines , a developer of laser-based, laboratory instrumentation. Its corporate headquarters and research labs are in Thousand Oaks. Financial terms of the buy were not disclosed. Teledyne said the acquisition was made through its subsidiary, Teledyne Instruments. Photon Machines was based in Bozeman, Montana.

Teledyne Completes CARIS Buy

socalTECH

Thousand Oaks-based Teledyne Technologies said this morning that it has completed the acquisition of Canadian software company CARIS. CARIS develops geospatial software for seafloor mapping and sonar processing. Financial details of the previously announced deal were not disclosed. CARIS was based in Fredericton, New Brunswick, Canada, and had been founded in 1979. READ MORE>>. teledyne caris merger acquisition software sonar geospatial mapping

Teledyne Enters Consumables Market For Extreme UV Lithography

socalTECH

Thousand Oaks-based Teledyne Technologies said it is entering the market for consumables for the extreme, ultraviolet lithography (EUV) semiconductor market. According to Teledyne, its subsidiary, Teledyne DALSA, is partnering with ASML Holding N.V. to produce pellicle membranes for use in Extreme Ultraviolet (EUV) lithography-based semiconductor fabrication.

Teledyne Completes Scientific Systems Acquisition

socalTECH

Thousand Oaks-based Teledyne Technologies said on Thursday that it has completed its acquisition of the assets of Pennsylvania-based Scientific Systems Inc. SSI is a manufacturer of precision components and specialized subassemblies used in analytical and diagnostic instrumentation, such as High Performance Liquid Chromatography (HPLC) systems. Financial details of the acquisition were not announced. READ MORE>>.

Teledyne Buys Scientific Systems

socalTECH

Thousand Oaks-based Teledyne Technologies announced on Thursday that it has acquired Scientific Systems, Inc. , a manufacturer of precision components and specialized subassemblies for the High Performance Liquid Chromatography (HPLC) and specialized medical devices market. Financial terms of the buy were not announced. Teledyne said it made the acquisition through its subsidiary, Teledyne Instruments, Inc. Scientific Systems was founded in 1967. READ MORE>>.

Amgen Leads Investment In SiteOne Therapeutics

socalTECH

Thousand Oaks-based Amgen is the lead investor in a round for San Francisco- and Bozeman, Montana-based SiteOne Therapeutics , SiteOne said on Friday. SiteOne said it raised $15M in a Series B funding round, which was led b Amgen, and also included Next Frontier Capital and insiders. SiteOne is developing no-opioid analgesics, aimed at treating chronic pain without causing addiction. READ MORE>>.

Teledyne Buys MEMS Foundry Micralyne

socalTECH

Thousand Oaks-based Teledyne Technologies announced this morning that it has acquired Canadian MEMs foundry Micralyne. Financial terms of the acquisition were not annoucned. Micralyne was based in Edmonton, Alberta, and is a foundry that produces Micro Electro Mechanical Systems (MEMS) devices, including microfluidic technoogy for biotech applications. Teledyne said that Micralyne also has capabilities in non-silicon-based MEMS (e.g.

Dyve Biosciences Names Chief Scientific Officer

socalTECH

Thousand Oaks-based Dyve Biosciences , a biotech company developing drug delivery technology, has named Chuck Harbert, Ph.D. as its Chief Scientific Officer. Harbert was previously at Pfizer, and had served as Vice President, US Exploratory Development and Strategic Planning for Pfizer, among other positions.

Amgen Expands Oncology Efforts In China With BeiGene

socalTECH

Thousand Oaks-based Amgen announced Thursday that it has entered into a strategic collaboration with BeiGene the expand its oncology research efforts in China. According to Amgen, it paid $2.8 billion in cash to acquire a 20.5 percent stake in BeiGene. Amgen said the move will "significantly accelerate" its plans to expand its oncology efforts in China. BeiGene has approximately 900 people in its commercial organization and 600 people in clinical development, according to Amgen.

Amgen Seeks To Acquire Nuevolution For $167M

socalTECH

Thousand Oaks-based biotech giant Amgen has made a $167M offer for Danish company Nuevolution , saying early this morning that it made a cash offer of SEK 32.50 per share for publicly listed Nuevolution, a developer of small molecule drugs. Nuevolution is based in Copenhagen, Denmark, and develops small molecule drugs focused on treatment of targets within inflammation, oncology and immuno-oncology.

Capsida Uncloaks With $140M In Funding

socalTECH

Thousand Oaks-based Capsida Biotherapeutics, a new biotechnology company focused on using adeno-associated virus (AAV) engineering and cargo development platform to develop tissue-targeted gene therapies for multiple types of diseases, has uncloaked from stealth mode, saying it has raised $140M in total capital.

Move Acquired By News Corp.

socalTECH

Move has operations in the Thousand Oaks, California area, although it is now based in San Jose. The company was started in Thousand Oaks in 1993, and now has 913 employees. Move, Inc. , the operator of the Realtor.com, Move.com, and other related real estate businesses, is being acquired by News Corp. , in a deal worth approximately $950M, the two companies said this morning.

News 143

Amgen Gets FDA Approval On Kidney Disease Treatment

socalTECH

Thousand Oaks-based Amgen said late Tuesday that it has received U.S. Food and Drug Administration (FDA) approval on a treatment for kidney disease. Amgen said the FDA approved Parsabiv (etelcalcetide) for the treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on hemodialysis. According to the company, its new treatment is the first approved for the condition in 12 years. READ MORE>>.

Amgen In Precision Medicine Deal With Syapse

socalTECH

Thousand Oaks-based biotechnology giant Amgen has entered into a new collaboration effort, with precision medicine developer Syapse. According to the two companies, they will develop observational research analytics to assess treatment outcomes for areas of unmet need in oncology.

Amgen Takes Stake In Chinese Oncology Company

socalTECH

Thousand Oaks-based Amgen said on Thursday afternoon that it has taken a 20.5 percent stake in BeiGene , a research-based, oncology-focused biotechnology company in China. According to Amgen, it paid approximately $2.7 billion in cash for the stake in BeiGene, which it says it will use to expand its oncology presence in China. BeiGene has a 700-person commercial organization and 600-person clinical development organization, according to Amgen.

Teledyne Buys Bowtech For Underwater Cameras

socalTECH

Thousand Oaks-based Teledyne said Monday that it has acquired Bowtech Products Limited , an Aberdeen, Scotland maker of underwater vision systems. Financial terms of the buy were not disclosed. Bowtech''s cameras are used in remotely operated vehicles (ROVs) and other harsh underwater systems, and was founded in 1989. Teledyne said the buy helps fill a product gap in its marine technology portfolio. READ MORE>>.

Teledyne Gets $178M In Special Operations Contract

socalTECH

Thousand Oaks-based Teledyne Technologies reported this morning that it has scored a $178M contract, to product underwater combat submersibles for the Special Forces. According to Teledyne, the contract win came for Teledyne Brown Engineering, its subsidiary in Huntsville, Alabama, from the Naval Sea Systems Command (NAVSEA).

Ceres Acquired For $17.2M

socalTECH

Thousand Oaks-based agricultural biotech developer Ceres is being acquired by Minnesota-based agriculture firm Land O'Lakes , in a deal worth approximately $17.2M, the companies said on Friday. The two said that Land O'Lakes will pay $0.40 per share, in cash, for Ceres. Ceres will become part of Land O'Lakes Forage Genetics International (FGI) subsidiary. Ceres said the acquisition came after evaluating strategic options, and was unanimously backed by its board of directors.

Teledyne Wins $20M F-35 Contract

socalTECH

Teledyne Advanced Electronics Solutions (AES), a business unit of Thousand Oaks-based Teledyne , reports this morning that it has won a $20M contract related to its support of the F-35 aircraft program. According to Teledyne, the contract--which runs for fiscal years 2019 through 2021--is with Harris Corporation.Teledyne AES said the award is to develop and deliver fiber optic quad transceiver products for the military aircraft.

Teledyne Wins Air Force Contract

socalTECH

Thousand Oaks-based Teledyne Technologies has won a contract from the United States Air Force, for laser eye protection spectacles, initially worth $7.7M, with the potential to be worth as much as $20.4M. The win was made through its Teledyne Scientific and Imaging subsidiary, which has its operations in Thousand Oaks and Camarillo.